Kusajili – Clinical trials directory

Result of your search per sponsor: Thomas Brodowicz, Prof

Woman Max 99 years
Thomas Brodowicz, Prof Update Il y a 4 ans

Dose Density FU 75 and FU 90 as Adjuvant Therapy for Early Breast Cancer This is an open -label randomized phase II study of dose-dense Fluorouracil/Epirubicin/Cyclophosphamide (FEC) administered with Epirubicin of 75mg/m2 (FEC75) and Epirubicin 90mg/m2 (FEC90)...

Country Austria, Hungary, Poland, Slovakia
organs None
Specialty None

Closed trial

More information